Highly pure (>95%) terminally differentiated neurons derived from pluripotent stem cells appear healthy at 2 weeks after infection with varicella-zoster virus (VZV), and the cell culture medium contains no infectious virus. Analysis of the healthy-appearing neurons revealed VZV DNA, transcripts, and proteins corresponding to the VZV immediate early, early, and late kinetic phases of replication. Herein, we further characterized virus in these neuronal cells, focusing on (i) transcription and expression of late VZV glycoprotein C (gC) open reading frame 14 (ORF14) and (ii) ultrastructural features of virus particles in neurons. The analysis showed that gC was not expressed in most infected neurons and gC expression was markedly reduced in a minority of VZV-infected neurons. In contrast, expression of the early-late VZV gE glycoprotein (ORF68) was abundant. Transcript analysis also showed decreased gC transcription compared with gE. Examination of viral structure by high-resolution transmission electron microscopy revealed fewer viral particles than typically observed in cells productively infected with VZV. Furthermore, viral particles were more aberrant, in that most capsids in the nuclei lacked a dense core and most enveloped particles in the cytoplasm were light particles (envelopes without capsids). Together, these results suggest a considerable deficiency in late-phase replication and viral assembly during VZV infection of neurons in culture.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754126PMC
http://dx.doi.org/10.1128/JVI.01506-13DOI Listing

Publication Analysis

Top Keywords

vzv glycoprotein
8
viral particles
8
neurons
7
vzv
7
particles
5
aberrant virion
4
virion assembly
4
assembly limited
4
limited glycoprotein
4
glycoprotein production
4

Similar Publications

A VZV-gE subunit vaccine decorated with mPLA elicits protective cellular immmune responses against varicella-zoster virus.

Int Immunopharmacol

January 2025

Department of Pharmaceutics, School of Pharmacy, Ningxia Medical University, Yinchuan, Ningxia, China. Electronic address:

Herpes zoster is an acute infectious skin disease caused by the reactivation of latent varicella-zoster virus, vaccination, such as subunit vaccine with good safety, can effectively prevent shingles through increasing immunity of the body. However, protein antigens are prone to degradation and inactivation, which alone is generally not sufficient to induce potent immune effect. In this study, the liposomal vaccine platform modified with mPLA (TLR4 agonist) was developed to improve the immunogenicity of glycoprotein E (VZV-gE) derived from herpes zoster virus.

View Article and Find Full Text PDF

Herpes zoster (HZ) is increasingly common in the aging and is experienced by approximately one in three people in their lifetime. It is also relatively common in immune-compromised people. Acute HZ causes severe pain, reduced quality of life and severe complications, including prolonged pain, or postherpetic neuralgia (PHN), and ocular zoster, which may rarely progress to blindness.

View Article and Find Full Text PDF

VZV IE4 downregulates cellular surface MHC-I via sequestering it to the Golgi complex.

Cell Mol Life Sci

December 2024

Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.

Article Synopsis
  • Varicella-zoster virus (VZV) infection reduces surface expression of MHC-I by retaining it in the Golgi complex, but the mechanism behind this is not fully clear.
  • The study identifies the VZV IE4 protein as a key factor that interacts with the human leukocyte antigen C (HLA-C), leading to its co-localization in the Golgi and downregulation of MHC-I on the cell surface.
  • A mutated version of IE4 (mIE4) restores MHC-I surface expression, indicating that VZV IE4 plays a role in evading host immune responses by disrupting the MHC-I presentation pathway.
View Article and Find Full Text PDF

: Janus kinase (JAK) inhibitors have emerged as a new class of disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis (RA). However, herpes zoster is one of the common adverse events of JAK inhibitors, including upadacitinib, which is especially high in Japanese patients with RA compared to those from Western countries. Recombinant zoster vaccine (Shingrix) is an adjuvanted subunit vaccine containing varicella-zoster virus (VZV) glycoprotein E (gE) that is effective in adults over 50 years of age.

View Article and Find Full Text PDF

Truncated VZV gE Induces High-Titer Neutralizing Antibodies in Mice.

Vaccines (Basel)

October 2024

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

A contemporary public health challenge is the increase in the prevalence rates of herpes zoster (HZ) worldwide. In this work, the gE gene structure was analyzed using bioinformatics techniques, and three plasmids of varying lengths, tgE537, tgE200, and tgE350, were expressed in Chinese hamster ovary (CHO) cells. These proteins were used to immunize BALB/c mice with Al/CpG adjuvant; ELISPOT and FCM were used to evaluate cellular immunity; and ELISA, VZV microneutralization, and FAMA assays were performed to detect antibody titers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!